expert reaction to abstract of Phase 3 INTerpath-001 trial results of an individualised mRNA vaccine for resected stage IIB-IV melanoma, due to be presented at ESMO
Scientists comment on an abstract of Phase 3 INTerpath-001 trial results of an individualised mRNA vaccine for resected stage … read more